Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Apply now: Request for Licensing Application Packet Form | Questions: ra-licensuredivision@pa.gov
Pennsylvania Drug and Alcohol Outpatient Licensing: The Same Chapter, Different Standards Inside It
Outpatient SUD treatment in Pennsylvania sits under the same Chapter 709 framework as residential care, with the same DDAP oversight, but the standards that actually apply to your program depend heavily on the specific service you’re licensed to deliver.
Staffing and physical plant standards still apply
Chapter 704’s staffing requirements and Chapter 705’s physical plant standards apply to outpatient programs the same way they apply to residential ones, so an outpatient license doesn’t mean a lighter compliance file, just a different physical footprint. DDAP reviews both as part of licensure, and having them squared away before you submit is what actually shortens your real-world timeline, not the pace of DDAP’s own review.
Narcotic treatment needs a separate approval on top of the license
If your outpatient program includes methadone or another narcotic-based medication treatment, Chapter 715 applies. It isn’t a separate license. It’s an approval that sits on top of your DDAP facility license, and the program also needs a DEA registration and SAMHSA certification before it opens its doors to patients. A program can hold a general Chapter 709 outpatient license and still need Chapter 715 approval if it adds narcotic treatment services later. One doesn’t automatically extend to cover the other.
The annual inspection cycle applies here too
Outpatient Chapter 709 licenses run on the same one-year cycle as residential licenses, with DDAP scheduling an annual on-site inspection ahead of renewal. Treating outpatient licensure as a lighter, less frequently reviewed category than residential care is a mistake, because the review cadence is identical.
Medication-assisted treatment
Outpatient programs should maintain a real pathway to medication-assisted treatment, whether or not they hold Chapter 715 narcotic treatment authorization directly. A working relationship with a buprenorphine or naltrexone prescriber, or a genuine coordination arrangement with a licensed narcotic treatment program, matters more to both clients and DDAP than a referral list that goes cold.
A Ketamine Clinic Next to a Pennsylvania Outpatient Program
Based on Pennsylvania case law on corporate practice, DDAP’s activity licensing and the state’s nurse practitioner rules. Pennsylvania has no ketamine clinic rules, so treat this as a framework for counsel.
Pennsylvania doesn’t prohibit stand-alone ketamine clinics. DDAP licenses drug and alcohol activities, so a clinic treating depression with ketamine sits outside DDAP’s licensing and usually runs as a separate medical practice beside the outpatient program.
Structuring the Practice
The ownership rule here is judge-made. Pennsylvania courts limit ownership of a medical practice to licensed professionals, and the management agreements that draw the most scrutiny are the ones with long terms, MSO control over clinical matters, or a split of profits that starts to look like a partnership. A management agreement for a ketamine clinic should run on a shorter renewable term, leave every clinical call with the physicians and pay the MSO a fixed fee rather than a cut of revenue. The clinic itself is typically a physician-owned professional corporation or, when organized as an LLC, a restricted professional company, which is the form the Pennsylvania Department of State requires for an LLC rendering medicine and surgery.
Running It Next to a DDAP Program
Keep the clinic’s records, schedules and ketamine supply separate from the licensed outpatient activity, with ketamine under the clinic’s own DEA registration, and get written consent under 42 CFR Part 2 before a client’s addiction treatment record goes to the clinic. If the outpatient provider instead tries to bring ketamine under its DDAP license, the 90-day change-in-activity report under 28 Pa. Code § 709.14 comes into play, an unreported change makes the license expire automatically, and DDAP should be asked whether the addition needs a new application on top of that report. Nurse practitioners in the clinic work under collaborative agreements with physicians that should name ketamine explicitly.
How to Submit Your DDAP Application
Outpatient programs use the same Request for Licensing Application Packet Form as residential facilities, selecting outpatient as the proposed activity. Email it to ra-licensureapps@pa.gov. For general questions, DDAP’s Division of Licensing Operations can be reached at ra-licensuredivision@pa.gov.
Where This Fits In
This covers outpatient licensing under Chapter 709 specifically. See Pennsylvania Behavioral Health Licensing for the full picture.
This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.
Determining whether your Pennsylvania program needs Chapter 715 narcotic treatment approval too?
Sources
- Pennsylvania DDAP: How to apply for a drug and alcohol treatment facility license, including the application packet request form, rev. 02-2025 and DDAP’s licensing email contacts (checked October 9, 2026)
- Pennsylvania Department of State: Pennsylvania Limited Liability Company, restricted professional companies (checked October 9, 2026)
- 28 Pa. Code § 704.1, via Justia: Who the staffing chapter covers (checked October 8, 2026)
- 28 Pa. Code Chapter 705, via Justia: Physical plant standards for nonresidential facilities (checked October 8, 2026)
- 28 Pa. Code §§ 709.11 and 709.14, via Justia: Annual license term and inspection and Activity changes and automatic expiration (checked October 8, 2026)
- 28 Pa. Code § 715.3, via Justia: Narcotic treatment program approval, DEA and SAMHSA (checked October 8, 2026)
- 49 Pa. Code § 21.285, via Justia: CRNP collaborative agreements and drug categories (checked October 8, 2026)

Leave a Reply